| Mary Clarke, MD | |
|
1815 W 6th Ave, Stillwater, OK 74074-4202 | |
| (405) 743-7300 | |
| (405) 743-7398 |
| Full Name | Mary Clarke |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 1815 W 6th Ave, Stillwater, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194839589 | NPI | - | NPPES |
| 1730673 01 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | L8314 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stillwater Medical Center Home Health Services | Stillwater, OK | Home health agency |
| Stillwater Medical Center | Stillwater, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stillwater Medical Center Authority | 2365353794 | 143 |
News Archive
Regeneron Pharmaceuticals, Inc. announced financial and operating results for the second quarter of 2010. The Company reported a net loss of $25.5 million, or $0.31 per share (basic and diluted), for the second quarter of 2010 compared with a net loss of $14.9 million, or $0.19 per share (basic and diluted), for the second quarter of 2009.
Our brains are so primed to recognize faces - or to tell people apart - that we rarely even stop to think about it, but what happens in the brain when it engages in such recognition is still far from understood. In a new study reported today in Nature Communications, researchers at the Weizmann Institute of Science have shed new light on this issue.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
Five researchers seeking to understand the causes of premature birth with the goal of identifying women at risk of preterm labor and developing new treatments to prevent it have been awarded grant support from the March of Dimes.
› Verified 1 days ago
| Entity Name | Stillwater Medical Center Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558377135 PECOS PAC ID: 2365353794 Enrollment ID: O20040525001304 |
News Archive
Regeneron Pharmaceuticals, Inc. announced financial and operating results for the second quarter of 2010. The Company reported a net loss of $25.5 million, or $0.31 per share (basic and diluted), for the second quarter of 2010 compared with a net loss of $14.9 million, or $0.19 per share (basic and diluted), for the second quarter of 2009.
Our brains are so primed to recognize faces - or to tell people apart - that we rarely even stop to think about it, but what happens in the brain when it engages in such recognition is still far from understood. In a new study reported today in Nature Communications, researchers at the Weizmann Institute of Science have shed new light on this issue.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
Five researchers seeking to understand the causes of premature birth with the goal of identifying women at risk of preterm labor and developing new treatments to prevent it have been awarded grant support from the March of Dimes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Clarke, MD 1815 W 6th Ave, Stillwater, OK 74074-4202 Ph: (405) 743-7300 | Mary Clarke, MD 1815 W 6th Ave, Stillwater, OK 74074-4202 Ph: (405) 743-7300 |
News Archive
Regeneron Pharmaceuticals, Inc. announced financial and operating results for the second quarter of 2010. The Company reported a net loss of $25.5 million, or $0.31 per share (basic and diluted), for the second quarter of 2010 compared with a net loss of $14.9 million, or $0.19 per share (basic and diluted), for the second quarter of 2009.
Our brains are so primed to recognize faces - or to tell people apart - that we rarely even stop to think about it, but what happens in the brain when it engages in such recognition is still far from understood. In a new study reported today in Nature Communications, researchers at the Weizmann Institute of Science have shed new light on this issue.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
Five researchers seeking to understand the causes of premature birth with the goal of identifying women at risk of preterm labor and developing new treatments to prevent it have been awarded grant support from the March of Dimes.
› Verified 1 days ago
Dr. Jane L Curtis, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1202 W Farm Rd, Stillwater, OK 74078 Phone: 405-744-7024 Fax: 405-744-6556 | |
Elizabeth Ashley Gallaway, APRN Family Medicine Medicare: Medicare Enrolled Practice Location: 1323 W 6th Ave, Stillwater, OK 74074 Phone: 405-372-1480 | |
Dr. Garrick Lee Shreck, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1921 W 6th Ave Ste A, Stillwater, OK 74074 Phone: 405-533-2433 Fax: 833-623-1821 | |
Melissa Shanay Herring, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1815 W 6th Ave, Stillwater, OK 74074 Phone: 405-743-7300 | |
Dr. Daniel Adrian Brown, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1815 W 6th Ave, Stillwater, OK 74074 Phone: 405-743-7300 | |
Monica Elaine Harden, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1921 W 6th Ave Ste A, Stillwater, OK 74074 Phone: 405-533-2433 Fax: 833-623-1822 |